SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-021374
Filing Date
2018-08-03
Accepted
2018-08-03 16:06:55
Documents
1
Period of Report
2018-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3978
  Complete submission text file 0000899243-18-021374.txt   5573
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10

Mailing Address C/O CORNERSTONE THERAPEUTICS INC 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address
Price David (Reporting) CIK: 0001449336 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 18991865